These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16296391

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
    Yoshiyama T, Ito K, Ogata H, Aono A, Wada M.
    Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of multi-drug resistant tuberculosis].
    Okumura M, Kudoh S.
    Nihon Rinsho; 2011 Aug; 69(8):1394-9. PubMed ID: 21838036
    [Abstract] [Full Text] [Related]

  • 24. Public-private collaboration for multidrug-resistant tuberculosis control in New York City.
    Munsiff SS, Ahuja SD, Li J, Driver CR.
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):639-48. PubMed ID: 16776451
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
    Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, Lee JK, Kim SJ.
    Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
    [Abstract] [Full Text] [Related]

  • 29. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 30. [Exogenous re-infection in tuberculosis].
    Tsuchiya T.
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [Abstract] [Full Text] [Related]

  • 31. [The use of nationwide tuberculosis surveillance system data to determine geographical differences in drug resistance--consideration of the representativeness of the drug resistance rate in Japan].
    Ohmori M, Ito K, Uchimura K, Yamauchi Y, Shimouchi A, Yoshiyama T, Mitarai S, Ishikawa N.
    Kekkaku; 2011 Jul; 86(7):729-35. PubMed ID: 21922783
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
    Ogawara M, Sakatani M.
    Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Multidrug-resistant tuberculosis in a hospital--Jersey City, New Jersey, 1990-1992.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Jun 10; 43(22):417-9. PubMed ID: 8196587
    [Abstract] [Full Text] [Related]

  • 36. [Anti-tuberculosis chemotherapy].
    Wada M.
    Kekkaku; 2007 Oct 10; 82(10):771-81. PubMed ID: 18018601
    [Abstract] [Full Text] [Related]

  • 37. High rate of transmission among contacts in large London outbreak of isoniazid mono-resistant tuberculosis.
    Neely F, Maguire H, Le Brun F, Davies A, Gelb D, Yates S.
    J Public Health (Oxf); 2010 Mar 10; 32(1):44-51. PubMed ID: 19542269
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.
    Int J Tuberc Lung Dis; 2006 Aug 10; 10(8):844-50. PubMed ID: 16898367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.